Adavosertib and beyond: Biomarkers, drug combination and toxicity of WEE1 inhibitors
- PMID: 38103761
- DOI: 10.1016/j.critrevonc.2023.104233
Adavosertib and beyond: Biomarkers, drug combination and toxicity of WEE1 inhibitors
Abstract
WEE1 kinase is renowned as an S-G2 checkpoint inhibitor activated by ATR-CHK1 in response to replication stress. WEE1 inhibition enhances replication stress and effectively circumvents checkpoints into mitosis, which triggers significant genetic impairs and culminates in cell death. This approach has been validated clinically for its promising anti-tumor efficacy across various cancer types, notably in cases of ovarian cancers. Nonetheless, the initial stage of clinical trials has shown that the first-in-human WEE1 inhibitor adavosertib is limited by dose-limiting adverse events. As a result, recent efforts have been made to explore predictive biomarkers and smart combination schedules to alleviate adverse effects. In this review, we focused on the exploration of therapeutic biomarkers, as well as schedules of combination utilizing WEE1 inhibitors and canonical anticancer drugs, according to the latest preclinical and clinical studies, indicating that the optimal application of WEE1 inhibitors will likely be as part of dose-reducing combination and be tailored to specific patient populations.
Keywords: Adavosertib; Adverse effects; Biomarkers; Combination strategy; WEE1.
Copyright © 2023 Elsevier B.V. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest We have no conflicts of interest to disclose.
Similar articles
-
Differential Activity of ATR and WEE1 Inhibitors in a Highly Sensitive Subpopulation of DLBCL Linked to Replication Stress.Cancer Res. 2019 Jul 15;79(14):3762-3775. doi: 10.1158/0008-5472.CAN-18-2480. Epub 2019 May 23. Cancer Res. 2019. PMID: 31123088
-
Differential properties of mitosis-associated events following CHK1 and WEE1 inhibitor treatments in human tongue carcinoma cells.Exp Cell Res. 2020 Jan 15;386(2):111720. doi: 10.1016/j.yexcr.2019.111720. Epub 2019 Nov 15. Exp Cell Res. 2020. PMID: 31738907
-
Single-agent Adavosertib Shows Anticancer Effects Against Colorectal Cancer Cells.Anticancer Res. 2024 Nov;44(11):4941-4949. doi: 10.21873/anticanres.17319. Anticancer Res. 2024. PMID: 39477317
-
Inhibitors of cell cycle checkpoint target Wee1 kinase - a patent review (2003-2022).Expert Opin Ther Pat. 2022 Dec;32(12):1217-1244. doi: 10.1080/13543776.2022.2166827. Epub 2023 Jan 19. Expert Opin Ther Pat. 2022. PMID: 36620912 Review.
-
WEE1 kinase limits CDK activities to safeguard DNA replication and mitotic entry.Mutat Res. 2020 Jan-Apr;819-820:111694. doi: 10.1016/j.mrfmmm.2020.111694. Epub 2020 Feb 25. Mutat Res. 2020. PMID: 32120135 Review.
Cited by
-
Targeting the DNA damage response in cancer.MedComm (2020). 2024 Oct 31;5(11):e788. doi: 10.1002/mco2.788. eCollection 2024 Nov. MedComm (2020). 2024. PMID: 39492835 Free PMC article. Review.
-
High WEE1 expression is independently linked to poor survival in multiple myeloma.bioRxiv [Preprint]. 2024 Sep 24:2024.09.20.613788. doi: 10.1101/2024.09.20.613788. bioRxiv. 2024. Update in: Blood Cancer J. 2025 Feb 20;15(1):22. doi: 10.1038/s41408-025-01230-y. PMID: 39386721 Free PMC article. Updated. Preprint.
-
Poly (ADP-ribose) polymerase inhibitor therapy and mechanisms of resistance in epithelial ovarian cancer.Front Oncol. 2024 Jul 29;14:1414112. doi: 10.3389/fonc.2024.1414112. eCollection 2024. Front Oncol. 2024. PMID: 39135999 Free PMC article. Review.
-
Novel Indazole Compounds as PKMYT1 Kinase Inhibitors for Treating Cancer.ACS Med Chem Lett. 2024 Oct 12;15(11):1810-1811. doi: 10.1021/acsmedchemlett.4c00486. eCollection 2024 Nov 14. ACS Med Chem Lett. 2024. PMID: 39563798
-
Antibody-drug conjugates in gastric cancer: from molecular landscape to clinical strategies.Gastric Cancer. 2024 Sep;27(5):887-906. doi: 10.1007/s10120-024-01529-y. Epub 2024 Jul 4. Gastric Cancer. 2024. PMID: 38963593 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous